Sumary of INCB, UNODC and WHO call on governments to facilitate access to controlled medicines in emergencies:
- The theme of World Humanitarian Day 2021 acknowledged the impact of climate-related emergencies.
- The impact of their increasing number combined with the persistent COVID-19 pandemic creates a complex landscape for ensuring access to controlled medicines in emergencies.
- A year after an earlier joint statement, unprecedented trade restrictions, shortages of medicines, surges in infections and new variants of SARS-CoV-2 compound the problems related to maintaining supply of controlled medicines, according to WHO and the World Trade Organization.
- The problem of access to controlled medicines in emergencies There is an increase in demand for controlled medicines in emergency responses.
- Low- and middle-income countries (LMIC) are often disproportionately impacted by shortages–partly related to their relative purchasing power in international medicines markets and partly because specialized systems to manage controlled medicines do not always accommodate sufficient exceptions for emergencies.
- Urgent action is needed to ensure that national systems improve access to controlled medicines for people affected by emergencies, including pandemics, and climate-related disasters.
- Action by governments and the international community Related StoriesWHO guidelines on controlled medicines in emergencies outline simplified control measures for the cross-border trade of controlled medicines during humanitarian emergencies.
- They have been adapted into operational terms in the Inter-Agency Emergency Health Kit guidance.